‘Two Minutes To Midnight’ For Germany’s Medtechs – Spectaris At Medica 2023
Urgent action to secure EU regulatory change; monitoring risk of PFAS ban
Germany’s hospital reform will alter the local medtech market in ways yet to be fully appreciated. Furthermore, economic, supply chain and regulatory pressures have pushed the hands of Germany’s medtech Doomsday Clock closer to midnight. So says Marcus Kuhlmann, head of medtech division at the Spectaris industry association, in part 3 of Medtech Insight’s German industry updates from Medica 2023.
